TipRanks
Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh (KR:950210)
:950210
South Korea Market
950210
Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh
RESEARCH TOOLSreports

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh (950210) Income Statement

― Followers

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh Income Statement

Last quarter (Q4 2024), Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh's total revenue was ₩5.51B, a decrease of -29.96% from the same quarter last year. In Q4, Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh's net income was ₩-8.78B. See Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 25Jun 23Jun 22Jun 22
Total Revenue
₩ 14.31B₩ 26.06B₩ 689.08M₩ 0.00₩ 161.84M
Gross Profit
₩ -24.01B₩ -30.81B₩ -528.79M₩ -3.87B₩ 127.90M
Operating Expenses
₩ 43.27B₩ 62.15B₩ 45.44B₩ 118.59B₩ 12.38B
Depreciation and Amortization
₩ 21.78B₩ 32.75B₩ 16.27B₩ 3.87B₩ 11.66B
EBITDA
₩ 33.31B₩ -60.84B₩ -31.05B₩ -206.91B₩ 10.51B
Operating Income
₩ -67.28B₩ -93.58B₩ -62.78B₩ -118.82B₩ 1.03B
Other Income/Expenses
₩ 71.19B₩ -29.43B₩ 8.09B₩ -91.83B₩ -3.16B
Pretax Income
₩ 3.92B₩ -123.01B₩ -54.69B₩ -210.65B₩ -2.10B
Net Income
₩ 22.27B₩ -91.47B₩ -32.92B₩ -211.45B₩ 17.57B
Per Share Metrics
Basic EPS
₩ 370.61₩ -1.52K₩ -547.81₩ -3.52K₩ 292.35
Diluted EPS
₩ 370.61₩ -1.52K₩ -547.81₩ -3.52K₩ 292.35
Weighted Average Shares Outstanding
 60.10M 60.10M 60.10M 60.10M 60.10M
Weighted Average Shares Outstanding (Diluted)
 60.10M 60.10M 60.10M 60.10M 60.10M
Currency in KRW

Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh Earnings and Revenue History